Bio-Rad Labs (BIO) Misses Q3 EPS by 18c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $368.75 --0%
Revenue Growth %: -0.3%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
ANAB, ANIX, MNY, More
Revenue Growth %: -0.3%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $2.60, $0.18 worse than the analyst estimate of $2.78. Revenue for the quarter came in at $680.8 million versus the consensus estimate of $679.94 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Frequency Electronics (FEIM) Tops Q1 EPS by 12c
- KeyBanc Starts Eastman Chemical (EMN) at Sector Weight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
